Notify me when Ali Behbahani files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. | Common Stock, $0.00001 par value per share | 22% | 7,393,823 | Ali Behbahani | 09 Feb 2026 | ||||
| KRRO | Korro Bio, Inc. | Common Stock, par value $0.001 per share | 9.9% | $17,130,522 | 1,456,677 | Ali Behbahani | 10 Mar 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|